KRAS and colorectal carcinoma: In this review, we synthesize current knowledge on the gut microbiota, especially Fusobacterium nucleatum and genetic contributors to CRC, with an emphasis on Fn virulence mechanisms in addition to KRAS mutation biology as a prognostic and therapeutic biomarker.